Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Evan Chris Chen, M.D.


Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Chen EC, Gandler H, Tošic I, Fell GG, Fiore A, Pozdnyakova O, DeAngelo DJ, Galinsky I, Luskin MR, Wadleigh M, Winer ES, Leonard R, O'Day K, de Jonge A, Neuberg D, Look AT, Stone RM, Frank DA, Garcia JS. Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates. Clin Cancer Res. 2023 Mar 01; 29(5):878-887. PMID: 36534523.
    Citations:    Fields:    
  2. Chen EC, Johnston H, Patel AA. Targeted Therapy for MPNs: Going Beyond JAK Inhibitors. Curr Hematol Malig Rep. 2023 Jan 27. PMID: 36705855.
    Citations:    Fields:    
  3. Xie Z, Chen EC, Stahl M, Zeidan AM. Prognostication in myelodysplastic syndromes (neoplasms): Molecular risk stratification finally coming of age. Blood Rev. 2022 Nov 05; 101033. PMID: 36357283.
    Citations: 1     Fields:    
  4. Chen EC, Gibson W, Temoczko P, Connell NT, Handin R, Parnes AD. Emicizumab for the treatment of acquired hemophilia A: Retrospective review of a single-institution experience. Haemophilia. 2023 Jan; 29(1):84-89. PMID: 36163651.
    Citations: 1     Fields:    Translation:Humans
  5. Chen EC, Liu Y, Harris CE, Winer ES, Wadleigh M, Lane AA, Vedula RS, Lindsley RC, Copson KM, Charles A, Marty F, Neuberg D, DeAngelo DJ, Stone RM, Luskin MR, Issa NC, Garcia JS. Outcomes of antifungal prophylaxis for newly diagnosed AML patients treated with a hypomethylating agent and venetoclax. Leuk Lymphoma. 2022 08; 63(8):1934-1941. PMID: 35289704; PMCID: PMC9481998.
    Citations:    Fields:    
  6. Chen EC, Li S, Yang J, Zhang ML, Hasserjian R, Chen YB, Brunner AM, DeFilipp Z. Erythroid nuclear dysplasia is associated with inferior outcomes for patients with myelodysplastic syndrome undergoing allogeneic hematopoietic cell transplantation. Leuk Res. 2021 10; 109:106625. PMID: 34062365.
    Citations:    Fields:    Translation:HumansCells
  7. Moll M, Zon RL, Sylvester KW, Rimsans J, Chen EC, Ghosh AJ, Abston E, Kim A, Rutherford H, Mitre X, Hakim A, Connell NT, Battinelli E, Fredenburgh LE, Baron RM, Hobbs BD, Cho MH, Mittleman MA, Woolley AE, Connors JM. Intermediate versus standard dose heparin prophylaxis in COVID-19 ICU patients: A propensity score-matched analysis. Thromb Res. 2021 07; 203:57-60. PMID: 33940309; PMCID: PMC8053596.
    Citations: 2     Fields:    Translation:HumansCells
  8. Chen EC, Li S, Eisfeld AK, Luskin MR, Mims A, Jones D, Antin JH, Cutler CS, Koreth J, Ho VT, Gooptu M, Romee R, El-Jawahri A, McAfee SL, DeFilipp Z, Soiffer RJ, Chen YB, Fathi AT. Outcomes for Patients With IDH-Mutated Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation. Transplant Cell Ther. 2021 06; 27(6):479.e1-479.e7. PMID: 33840625.
    Citations: 1     Fields:    Translation:Humans
  9. Chen EC, Garcia JS. Does patient fitness play a role in determining first-line treatment of acute myeloid leukemia? Hematology Am Soc Hematol Educ Program. 2020 12 04; 2020(1):41-50. PMID: 33275683.
    Citations: 1     Fields:    Translation:Humans
  10. Chen EC, Zon RL, Battinelli EM, Connors JM. Approach to the Patient with COVID-19-Associated Thrombosis: A Case-Based Review. Oncologist. 2020 10; 25(10):e1500-e1508. PMID: 32881209; PMCID: PMC7461375.
    Citations: 2     Fields:    Translation:HumansCells
  11. Moll M, Zon RL, Sylvester KW, Chen EC, Cheng V, Connell NT, Fredenburgh LE, Baron RM, Cho MH, Woolley AE, Connors JM. VTE in ICU Patients With COVID-19. Chest. 2020 11; 158(5):2130-2135. PMID: 32710891; PMCID: PMC7674987.
    Citations: 36     Fields:    Translation:HumansCellsPHPublic Health
  12. Chen EC, Stefely JA, Dey BR, Dzik WH. Chemotherapy-sparing treatment of haemophagocytic lymphohistiocytosis with intravenous immunoglobulins and corticosteroids. BMJ Case Rep. 2020 May 05; 13(5). PMID: 32376661; PMCID: PMC7228143.
    Citations:    Fields:    Translation:Humans
  13. Chen EC, Werner L, Hobbs GS, Narayan R, Amrein PC, Fathi AT, Brunner AM. Cardiac and genetic predictors of cardiovascular risk in patients with myelodysplastic syndromes. Leuk Lymphoma. 2019 12; 60(12):3058-3062. PMID: 31120366.
    Citations: 2     Fields:    Translation:Humans
  14. Chen EC, Fathi AT, Brunner AM. Reformulating acute myeloid leukemia: liposomal cytarabine and daunorubicin (CPX-351) as an emerging therapy for secondary AML. Onco Targets Ther. 2018; 11:3425-3434. PMID: 29928134; PMCID: PMC6003284.
    Citations: 15     
  15. Kim PG, Bridgham K, Chen EC, Vidula MK, Pozdnyakova O, Brunner AM, Fathi AT. Incident adverse events following therapy for acute promyelocytic leukemia. Leuk Res Rep. 2018; 9:79-83. PMID: 29892554; PMCID: PMC5993355.
    Citations: 3     
  16. Chen EC, Loftus PD, Weber SC, Hoang NM, Gilbert J, Rosenthal A, Kummar S. Autoimmune Hemolytic Anemia Confers an Independent Risk Factor for Thrombosis: Retrospective Cohort Study Using the “STRIDE” Database. Ann Hematol Oncol. 2017; 7(4):1160.
  17. Mullins M, Jiang X, Bylsma LC, Fryzek JP, Reichert H, Chen EC, Kummar S, Rosenthal A. Cold agglutinin disease burden: a longitudinal analysis of anemia, medications, transfusions, and health care utilization. Blood Adv. 2017 May 23; 1(13):839-848. PMID: 29296728.
    Citations: 5     Fields:    
  18. Keller CJ, Chen EC, Brodsky K, Yoon JH. A case of butane hash oil (marijuana wax)-induced psychosis. Subst Abus. 2016 Jul-Sep; 37(3):384-386. PMID: 26820171.
    Citations: 10     Fields:    Translation:HumansAnimals
  19. Chen EC, Karl TA, Kalisky T, Gupta SK, O'Brien CA, Longacre TA, van de Rijn M, Quake SR, Clarke MF, Rothenberg ME. KIT Signaling Promotes Growth of Colon Xenograft Tumors in Mice and Is Up-Regulated in a Subset of Human Colon Cancers. Gastroenterology. 2015 Sep; 149(3):705-17.e2. PMID: 26026391; PMCID: PMC4550533.
    Citations: 19     Fields:    Translation:HumansAnimalsCells
  20. Chung JH, Larsen AR, Chen E, Bunz F. A PTCH1 homolog transcriptionally activated by p53 suppresses Hedgehog signaling. J Biol Chem. 2014 Nov 21; 289(47):33020-31. PMID: 25296753.
    Citations: 18     Fields:    Translation:HumansCells
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Chen's Networks
Click the
buttons for more information and interactive visualizations!
Concepts (105)
Co-Authors (48)
Similar People (60)
Same Department 
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.